Company / Inventory
Corcept Therapeutics Incorporated Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$12.9M
FY2025
5-year range
$5.0M / $12.9M
FY2021-FY2025
Trend
+3.7%
vs FY2024
Sector context
#84 of 105
Health Care
What the data says
Corcept Therapeutics Incorporated's inventory of $13M is lower than 80% of companies in the Health Care sector (FY2025). Inventory has increased for 5 consecutive years, from $5M in FY2020 to $13M in FY2025.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of +21.3%.
Improved from $8M to $13M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +28.3%
- 5-Year CAGR
- +21.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 105This company $12.9M Sector average $885.3M
▼
-98.5% below sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's inventory has grown for 5 consecutive years.
- 5-year CAGR of +21.3%, indicating consistent growth.
- In FY2025, inventory increased 3.7% year-over-year.
- Ranks #84 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.9M | +3.7% |
| FY2024 | $12.4M | +60.6% |
| FY2023 | $7.7M | +26.7% |
| FY2022 | $6.1M | +22.3% |
| FY2021 | $5.0M | +1.6% |
| FY2020 | $4.9M | -9.5% |
| FY2019 | $5.4M | +14.6% |
| FY2018 | $4.7M | +3.4% |
| FY2017 | $4.6M | +96.5% |
| FY2016 | $2.3M | +38.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026